Otsuka logo

Otsuka

OTSKY | OTC
Chart Builder DCF Calculator
$38.98
+$0.41 (+1.06%)
At close: Nov 16, 2026, 3:59 PM ET
$39.00
+$0.02 (+0.05%)
After-hours: Nov 16, 2026, 2:59 PM ET
+1.06%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
56.8
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #161/1021 (Top 16%)

Key Statistics

Market Data

Market Cap $40.84B
1D Range
38.34 39.51
52W Range
26.23 40.49

Valuation (TTM)

PE 22.99
PB 2.00
EV/EBITDA 9.79

Valuation (NTM)

Forward PE 17.06
Forward PEG 1.27
Price Target $0.00
Loading financial charts...

Profile

Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consu...

Sector Healthcare
Employees 37,758
IPO Date Aug 3, 2012
Fiscal Year n/a

Latest News

2 months ago · reuters.com

Otsuka, Ionis' experimental ALS drug meets main goal in late-stage study
Otsuka Announces Transformative Phase 3 FUSION Results for Ulefnersen, Bringing the FUS-ALS Community Closer to a Potential Targeted Treatment

2 months ago · businesswire.com

Otsuka Announces Transformative Phase 3 FUSION Results for Ulefnersen, Bringing the FUS-ALS Community Closer to a Potential Targeted Treatment
Otsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study Prepared Remarks Transcript

3 months ago · seekingalpha.com

Otsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study Prepared Remarks Transcript
Otsuka Holdings Co., Ltd. (OTSKY) Q2 2026 Earnings Call Prepared Remarks Transcript

3 months ago · seekingalpha.com

Otsuka Holdings Co., Ltd. (OTSKY) Q2 2026 Earnings Call Prepared Remarks Transcript
Aristotle Global Equity Advisory Q2 2026 Portfolio Review

4 months ago · seekingalpha.com

Aristotle Global Equity Advisory Q2 2026 Portfolio Review
Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America

4 months ago · prnewswire.com

Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America

Earnings

Latest Earnings
Oct 30, 2026
EPS
$0.64
Beat +9.03%
REV
$4.51B
Beat +1.95%
Next Earnings
Feb 12, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.